ValuationViz

SNDX fund manager activity

Syndax Pharmaceuticals, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q4 2020 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Torray FundsAdded133,835$2,925,6330.39%Jul 30, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Torray FundsAdded104,868$2,449,7160.36%May 1, 2026

Older quarters